A gift or a yoke? Women's and men's responses to genetic risk information from BRCA1 and BRCA2 testing

Clinical Genetics

Volumn 70, Issue 6, 2006, Pages 462-472

  d'Agincourt Canning, Lori ^a  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

BRCA1 and BRCA2; Genetic testing for hereditary breast and ovarian cancer; Risk perception; Self identity

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; AWARENESS; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; ETHNOGRAPHY; FAMILY RELATION; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; INTERVIEW; MALE; PATIENT INFORMATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL WELL BEING; QUALITATIVE ANALYSIS; SELF CONCEPT; SELF CONTROL; SOCIAL ASPECT; SOCIAL STATUS;

ADULT; BREAST NEOPLASMS; BRITISH COLUMBIA; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; RISK ASSESSMENT; SELF CONCEPT; SOCIAL IDENTIFICATION;

EID: 33751008420     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2006.00720.x     Document Type: Article

References (60)

1. Miki Y, Swenson J, Schattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene, BRCA1. Science 1994: 266: 66-71.
2. Wooster R, Bignell G, Swift S et al. Identification of the breast cancer susceptibility gene, BRCA2. Nature 1995: 378: 789-792.
3. USPSTF. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2005: 143(5): 362-379.
4. Struewing JP, Hartge P, Wacholder S et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997: 336: 1401-1408.
5. Peelen T, van Vliet M, Petrij-Bosch A et al. A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 1997: 60: 1041-1049.
6. Arason A, Jonasdottir A, Barkardottir R et al. A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: Two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland. J Med Genet 1998: 35: 446-449.
7. Einbeigi A, Bergman A, Kindblom LG. A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer. Eur J Cancer 2001: 37: 1904-1909.
8. Vezina H, Durocher F, Dumont M et al. Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families. Hum Genet 2005: 117: 119-132.
9. Kirchhoff T, Kauff N, Mitra N et al. BRCA mutations and risk of prostate cancer in Ashkenazi Jews. Clin Cancer Res 2004: 10(9): 2918-2921.
10. Liede AL, Karlan BY, Narod S. Cancer risks for male carriers of germline mutations in BRCA1 and BRCA2: A review of the literature. J Clin Oncol 2004: 22: 735-742.
11. Rebbeck TR, Friebel T, Lynch HT et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutations carriers: The PROSE Study Group. J Clin Oncol 2004: 22: 981-983.
12. Warner E, Plewes DB, Hill KA et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography and clinical breast examination. J Am Med Assoc 2004: 292: 1317-1325.
13. Meiser B. Psychological impact of genetic testing for cancer susceptibility: An update of the literature. Psychooncology 2005: 14: 1060-1074.
14. Croyle RT, Smith KR, Botkin J, Baty B, Nash J. Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychol 1997: 16(1): 63-72.
15. Di Prospero LS, Seminsky M, Honeyford J et al. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations. Findings from a focus group and a needs assessment survey. Can Med Assoc J 2001: 164(7): 1005-1009.
16. Meiser B, Butow P, Friedlander M et al. Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer 2002: 38: 2025-2031.
17. Lodder L, Frets PG, Trijsburg RW et al. Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet 2001: 98: 15-24.
18. Watson M, Foster C, Eeles R et al. Psychological impact of breast/ ovarian (BRCA 1/2) cancer-predictive genetic testing in a UK multi-centre cohort. Br J Cancer 2004: 91: 1787-1794.
19. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G. BRCA1 testing in families with hereditary breast/ovarian cancer. A prospective study of patient decision-making and outcomes. J Am Med Assoc 1996a: 275: 1885-1892.
20. Claes E, Evers-Kiebooms L, Denayer L et al. Predictive genetic testing for hereditary breast and ovarian cancer: Psychological distress and illness representations one year following disclosure. J Genet Couns 2005: 14(5): 349-363.
21. van Oostrom I, Meijers-Heijboer H, Lodder L et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: A five-year follow-up study. J Clin Oncol 2003: 21: 3867-3874.
22. Balmana J, Stoffel EM, Emmons KM, Garber JE, Syngal S. Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes. J Med Genet Online 2004: 41: e44.
23. d'Agincourt-Canning L. The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. J Genet Couns 2005: 14: 55-70.
24. d'Agincourt-Canning L. Genetic testing for hereditary breast and ovarian cancer: Responsibility and choice. Qual Health Res 2006: 16(1): 1-23.
25. Hallowell N, Foster C, Eeles R, Ardern-Jones A, Watson M. Accommodating risk: Responses to BRCA1/2 testing of women who had cancer. Soc Sci Med 2004: 59: 553-565.
26. Kenen R, Ardern-Jones A, Eeles RA. Family stories and the use of heuristics: Women from suspected hereditary breast and ovarian (HBOC) families. Sociol Health Illn 2003: 25(7): 838-865.
27. Hallowell N, Foster C, Ardern-Jones A, Eeles V, Murday V, Watson M. Genetic testing for women previously diagnosed with breast/ovarian cancer: Examining the impact of BRCA1 and BRCA2 mutation searching. Genet Test 2002: 6(2): 79-87.
28. Smith KR, West JA, Croyle RT, Botkin JR. Familial context of genetic testing for cancer susceptibility: Moderating effect of siblings'test results on psychological distress one to two weeks after BRCA1 testing. Cancer Epidemiol Biomarkers Prev 1999: 8: 385-392.
29. Lodder L, Frets PG, Trijsburg RW et al. The psychological impact of receiving BRCA1/BRCA2 test results. Am J Hum Genet 2000: 98: 15-24.
30. d'Agincourt-Canning L. Experiential knowledge, moral agency and genetic testing for hereditary breast/ovarian cancer. Unpublished Ph.D. Dissertation, University of British Columbia, Vancouver, 2003.
31. Abel EK, Browner CH. Selective compliance with biomedical authority and the uses of experiential knowledge. In: Lock M, Kaufert PA, eds. Pragmatic women and body politics. Cambridge: Cambridge University Press, 1998: 310-326.
32. Church J. Ownership and the body. In: Meyers DT, ed. Feminists rethink the self. Boulder, CO: Westview Press, 1997: 85-103.
33. Howson A. Embodied obligation: The female body and health surveillance. In: Nettleton S, Watson J, eds. The body in everyday life. New York: Routledge, 1998: 218-240.
34. Bury M. Chronic illness as biographical disruption. Sociol Health Illn 1982: 4: 167-182.
35. Bury M. The sociology of chronic illness: A review of research and prospects. Sociol Health Illn 1991: 13: 451-468.
36. Charmaz K. The body, identity and self: Adapting to impairment. Sociol Q 1995: 36: 657-680.
37. Kavanagh A, Broom D. Embodied risk: My body, myself? Soc Sci Med 1998: 46(3): 437-444.
38. Friedman M. Autonomy and social relationships: Rethinking the feminist critique. In: Meyers DT, ed. Feminists rethink the self. Boulder, CO: Westview Press, 1997: 55-58.
39. Held V. Feminist morality. Chicago: Chicago University Press, 1993.
40. Meyers DT. Intersectional identity and the authentic self: Opposites attract. In: MacKenzie C, Stoljar N, eds. ReFational autonomy: feminist perspectives on autonomy, agency and the social self. New York: Oxford University Press, 2000: 151-180.
41. Barclay L. Autonomy and the social self. In: MacKenzie C, Stoljar N, eds. Relational autonomy: Feminist perspectives on autonomy, agency and the social self. New York: Oxford University Press, 2000: 52-71.
42. Emerson RM, Fretz RI, Shaw LL. Writing ethnographic fieldnotes. Chicago: University of Chicago Press, 1995.
43. Hammersley M, Atkinson P. Ethnography: Principles in practice. New York: Routledge, 1995.
44. Beeson D, Doksum T. Family values and resistance to genetic testing. In: Hoffmaster B, ed. Bioethics in a social context. Philadelphia: Temple University Press, 2001: 153-179.
45. Glaser BG, Strauss A. The discovery of grounded theory. Chicago: Aldine, 1967.
46. Strauss A, Corbin J. Basics of qualitative health research. London: Sage, 1990.
47. Huggins M, Block M, Wiggins S et al. Predictive testing for Huntington disease in Canada: Adverse effects and unexpected results in those receiving decreased risk. Am J Hum Genet 1992: 42: 509-515.
48. Sobel S, Cowan D. Impact of genetic testing for Huntington disease on the family system. Am J Med Genet 2000a: 90: 49-59.
49. Sobel S, Cowan DB. The process of family reconstruction after DNA testing for Huntington disease. J Genet Couns 2000b: 9: 227-251.
50. Meiser B. Psychological impact of genetic testing for cancer susceptibility: An update of the literature. Psychooncology 2005: 14: 1060-1074.
51. Butow P, Lobb E, Meiser B, Barratt A, Tucker KM. Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: A systematic review. Med J Aust 2003: 178: 77-81.
52. Smith KR, Ellington L, Chan A, Croyle RT, Botkin J. Fertility intentions following testing for a BRCA1 gene mutation. Cancer Epidemiol Biomarkers Prev 2004: 13(5): 733-740.
53. Anido A, Carlson L, Taft L, Sherman S. Women's attitudes toward testing for fragile X carrier status: A qualitative analysis. J Genet Couns 2005: 14(4): 295-306.
54. Murphy R, Scheer J, Murphy Y, Mack R. Physical disability and social liminality: A study in the rituals of adversity. Soc Sci Med 1988: 26: 235-242.
55. Cox SM, McKellin W. 'There's this thing in our family': Predictive testing and the construction of risk for Huntington disease. Sociol Health Illn 1999: 21(5): 622-646.
56. Hallowell N, Foster C, Eeles R, Ardern-Jones A, Murday V, Watson M. Balancing autonomy and responsibility: The ethics of generating and disclosing genetic information. J Med Ethics 2003: 29: 74-83.
57. Elliott C. Pursued by happiness and beaten senseless: Prozac and the American dream. Hastings Cent Rep 2000: 30(2): 7-12.
58. McAllister M. Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. Clin Genet 2003: 64: 179-189.
59. Burke W, Daly M, Garber J et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II BRCA1 and BRCA2. J Am Med Assoc 1997: 277: 997-1003.
60. Hallowell N. Reconstructing the body or reconstructing the woman? In: Potts L, ed. Ideologies of breast cancer. London: Macmillan Press Ltd, 2000: 153-179.